A Long-term Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis

Abroad (travel likely)RecruitingPHASE3

Conditions

Hyperphosphatemia Patients on Hemodialysis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Taisho Pharmaceutical Co., Ltd selected site, Tokyo, Japan
Contact: Study coordinator (Taisho Director Taisho Pharmaceutical Co., Ltd selected site) · shu_chiken@taisho.co.jp · 81-3-3985-1118

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Clinical Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis

Hyperphosphatemia Patients on Hemodialysis

Abroad (travel likely)RecruitingPHASE3

Tokyo, Japan

A Phase 3 Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis With Phosphate Binders

Hyperphosphatemia Patients on Hemodialysis

Abroad (travel likely)RecruitingPHASE3

Tokyo, Japan

Evaluate the Efficacy and Safety of JMKX003002 in End-Stage Renal Disease Patients on Hemodialysis with Hyperphosphatemia

Hyperphosphatemia

Abroad (travel likely)RecruitingPHASE2

Guangzhou, China · Guangzhou, China